Up a level |
Backen, Alison C, Lopes, Andre, Wasan, Harpreet, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Duggan, Marian, Cunningham, David, Anthoney, Alan, Corrie, Pippa G, Madhusudan, Srinivasan, Maraveyas, Anthony et al (show 9 more authors)
(2018)
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
British Journal of Cancer, 119 (1).
pp. 27-35.
Jones, Robert P ORCID: 0000-0001-5608-001X, Psarelli, Eftychia-Eirini ORCID: 0000-0002-3102-0288, Jackson, Richard, Ghaneh, Paula, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Campbell, Fiona, Valle, Juan W, Faluyi, Olusola, O'Reilly, Derek A et al (show 92 more authors)
(2019)
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.
JAMA SURGERY, 154 (11).
pp. 1038-1048.
Jones, Robert ORCID: 0000-0001-5608-001X, Plummer, Ruth ORCID: 0000-0003-0107-1444, Moreno, Victor ORCID: 0000-0001-6099-4236, Carter, Louise ORCID: 0000-0002-9854-2304, Roda, Desamparados ORCID: 0000-0003-2657-9623, Garralda, Elena ORCID: 0000-0002-4412-7842, Kristeleit, Rebecca ORCID: 0000-0003-3825-1326, Sarker, Debashis ORCID: 0000-0003-4814-8429, Arkenau, Tobias ORCID: 0000-0002-2015-1549, Roxburgh, Patricia ORCID: 0000-0001-9869-591X et al (show 6 more authors)
(2023)
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 29 (2).
pp. 331-340.
Lamarca, Angela, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari et al (show 11 more authors)
(2021)
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
LANCET ONCOLOGY, 22 (5).
pp. 690-701.
Aughton, Karen ORCID: 0000-0002-5184-5789, Elander, Nils O, Evans, Anthony ORCID: 0000-0001-8547-1730, Jackson, Richard, Campbell, Fiona, Costello, Eithne, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Mackey, John R, Scarfe, Andrew G, Valle, Juan W et al (show 16 more authors)
(2021)
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
CANCERS, 13 (22).
5758-.